Militia Capital Partners LP Takes Position in Acadia Healthcare Company, Inc. $ACHC

Militia Capital Partners LP bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,400 shares of the company’s stock, valued at approximately $318,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC raised its holdings in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Federated Hermes Inc. increased its holdings in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after buying an additional 867 shares during the last quarter. Treasurer of the State of North Carolina increased its holdings in Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after buying an additional 867 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky increased its holdings in Acadia Healthcare by 1.5% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 79,730 shares of the company’s stock worth $1,974,000 after buying an additional 1,141 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $24.99 on Wednesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $2.30 billion, a PE ratio of -2.04, a P/E/G ratio of 8.34 and a beta of 0.69. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $30.20. The company has a 50-day moving average price of $25.56 and a two-hundred day moving average price of $20.18.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The firm had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the business earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. TD Cowen raised their price objective on shares of Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a report on Monday, May 4th. KeyCorp restated an “overweight” rating and set a $30.00 price objective on shares of Acadia Healthcare in a report on Wednesday, May 27th. Finally, UBS Group raised their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $26.85.

Check Out Our Latest Report on Acadia Healthcare

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Read More

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.